跳至主要内容
临床试验/NCT05213208
NCT05213208已完成不适用

Propofol Sedation of More Than 200 mg Enables Patients to Drive Home After Outpatient Colonoscopy Including Colorectal Polypectomy

Showa Inan General Hospital1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2022年1月16日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
300
试验地点
1
主要终点
Traffic accidents

研究概览

简要总结

This study examines that the use of >200 mg of propofol sedation enables patients to drive home safely after outpatient colonoscopy.

详细描述

The hospital policy of routine discharge to normal activity 1 hour after propofol mono-sedation for EGD or colonoscopy was approved by the ethics committee of Showa Inan General Hospital in January, 2004 (http://www.sihp.jp). The investigator' s subsequent experience verified the safety of this discharge policy which was reconfirmed in March 2014. Based on these studies, the upper limit of 200 mg was established for those allowed early discharge and driving to home.

This study examines that the use of >200 mg of propofol sedation enables patients to drive home safely 90-120 minutes after outpatient colonoscopy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • subjects who drive home by theirselves after colonoscopy using propofol sedation (>200 mg)

排除标准

  • Subjects who received emergency procedures
  • less than 20 years old pregnant American Society of Anesthesiologists (ASA) class III or IV, overweight (body weight >100 kg) allergic to the drugs used or its components (soybeans or eggs).

结局指标

主要结局

Traffic accidents

时间窗: 1 day

Number of traffic accidents

次要结局

  • Patient satisfaction(1 day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Akira Horiuchi

Chief of Digestive Disease Center

Showa Inan General Hospital

研究点 (1)

Loading locations...

相似试验